Nate Notwell, Co-Founder & CEO, Marley Health

Marley Health is using artificial intelligence and data-driven insights to bring a more proactive approach to veterinary healthcare.

Drawing on innovations from human health technology, the company is developing tools that help veterinarians and pet owners identify potential health concerns earlier, enabling more informed decisions and better outcomes for pets.

In this episode of Meet the Portfolio, CEO and Co-Founder Nate Notwell discusses why Marley Health was founded, the opportunities for innovation within veterinary medicine, and how technology can help reshape the future of pet healthcare.

The conversation covers the inspiration behind the business, the growing role of AI within healthcare, and the company’s vision for improving the lives of pets and their owners through earlier intervention and preventative care.

Watch the full video to learn more about Marley Health’s mission and progress to date.

To find out more about Marley Health, visit their website or our portfolio page here.

Access spinouts from the University of Oxford

Oxford Venture Fund

An early-stage investment fund backing technology spun out of the University of Oxford. These funds provide funding and support to companies founded on the University of Oxford’s research, helping transform these new scientific discoveries into tomorrow’s solutions.
Portfolio size
5+ companies
Stage
Seed-Series A
Tax reliefs
EIS tax reliefs available
Launch date
Coming soon
Find out more

The products shown on this website will place your capital at risk and investors may not get back the full amount invested. Past performance may not be repeated and is not indicative of future results.

Parkwalk funds invest in smaller and unquoted companies which carry a higher risk than many other forms of investment. There is no guarantee that target returns will be achieved. There is no liquid market for shares in unquoted companies and there can be difficulties, in valuing and disposing of investments in such companies. Tax reliefs will depend on the investors’ individual circumstance and are subject to change.

Parkwalk does not provide investment or tax advice, and the information on this website should not be construed as such. Parkwalk recommends investors seek advice from a regulated financial adviser that specialises in EIS fund investments before making an investment decision. An investment into any of the funds managed by Parkwalk may only be made on the basis of the information set out in the Information Memorandum and Key Information Document.

The information on this website is directed at United Kingdom residents only. Please confirm you have read this warning and are happy to proceed.